A hepatic sclerosed hemangioma with drastic changes in contrast-enhanced ultrasonography.


Journal

Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 10 06 2020
accepted: 12 07 2020
pubmed: 25 7 2020
medline: 29 6 2021
entrez: 25 7 2020
Statut: ppublish

Résumé

Hepatic sclerosed hemangioma is a rare benign liver tumor that originated from hepatic cavernous hemangioma; however, the process of its formation has been unclear. We herein present the patient of a histologically proven hepatic sclerosed hemangioma that showed drastic changes in diagnostic images in a short period. A 56-year-old man was referred to our hospital for the treatment of suspicious hepatocellular carcinoma with hepatitis C, approximately 2 cm in diameter in liver segment 8. Initially, the tumor manifested as early entire enhancement with mildly delayed washout in contrast-enhanced ultrasonography; however, it manifested as continuous peripheral enhancement with the central non-enhanced area after 1 month in various diagnostic images. He completely quit drinking and smoking 1 month preoperatively. No special symptoms and signs were found to suggest tumor ischemia. Anatomical resection of segment 8 was completed. Histological examination confirmed the final diagnosis of common type hepatic sclerosed hemangioma, derived from atypically enhancing cavernous hemangioma. No signs of impaired blood flow were observed in both diagnostic images and histological examination. Sclerosing changes in hepatic cavernous hemangioma may be completed in a relatively short time with no apparent reason.

Identifiants

pubmed: 32705537
doi: 10.1007/s12328-020-01194-5
pii: 10.1007/s12328-020-01194-5
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1252-1257

Auteurs

Shinichi Akahoshi (S)

Department of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan. r-star1@hotmail.co.jp.

Kensuke Yamamura (K)

Department of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.

Nobutaka Sato (N)

Department of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.

Eri Oda (E)

Department of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.

Koichi Kinoshita (K)

Department of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.

Hideaki Yuki (H)

Department of Radiology, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.

Toshihiko Motohara (T)

Department of Gastroenterology, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.

Akihiro Deguchi (A)

Department of Internal Medicine, Kagawa Rosai Hospital, 3-3-1 Jyoto, Marugame, Kagawa, 763‑8502, Japan.

Yoshihiro Komohara (Y)

Department of Cell Pathology, Graduate School of Life Sciences, Kumamoto University, 1-1-1, honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Toru Beppu (T)

Department of Surgery, Yamaga City Medical Center, 511 Yamaga, Kumamoto, 861-0593, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH